The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art
Abstract
Eosinophilic granulomatosis with polyangiitis (C hurg–S trauss, EGPA) is a systemic small‐vessel vasculitis associated with asthma and eosinophilia. Histology of EGPA shows tissue eosinophilia, necrotizing vasculitis, and eosinophil‐rich granulomatous inflammation. EGPA commonly presents with upper airway tract and lung involvement, peripheral neuropathy, cardiac and skin lesions. Antineutrophil cytoplasmic antibodies (ANCA) are positive in ∼40% of the cases and more often in patients with clinical manifestations due to small‐vessel vasculitis. The pathogenesis of EGPA is multifactorial: the disease can be triggered by exposure to allergens or drugs, but a genetic background has also been recognized, particularly an association with HLA‐DRB 4. Th 2 responses are prominent, with up‐regulation of IL‐4, IL‐13, and IL‐5; however, Th 1 and Th 17 responses are not negligible. Eosinophils are activated, have a prolonged lifespan and probably cause tissue damage by releasing their granule proteins; their tissue recruitment can be regulated by chemokines such as eotaxin‐3 and CCL 17. Humoral immunity is also dysregulated, as demonstrated by prominent I g G 4 and I g E responses. EGPA promptly responds to glucocorticoid therapy, although combinations of glucocorticoids and immunosuppressants (e.g., cyclophosphamide, azathioprine) are eventually required in most cases. Newer therapeutic options include the anti‐IL 5 antibody mepolizumab, whose efficacy has been described in small clinical trials, and the B‐cell‐depleting agent rituximab, reported in several case series.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Jennette, J. C., Falk, R. J., Bacon, P. A., Basu, N., Cid, M. C., Ferrario, F., Flores‐Suarez, L. F., Gross, W. L., Guillevin, L., Hagen, E. C., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37715 · Cited by 6,631
Nomenclature of Systemic Vasculitides
Jennette, J. C., Falk, R. J., Andrassy, K., Bacon, P. A., Churg, J., Gross, W. L., Hagen, E. C., Hoffman, G. S., Hunder, G. G., Kallenberg, C. G. M., et al. (1994) · Arthritis & Rheumatism · doi:10.1002/art.1780370206 · Cited by 3,845
Stone, J. H., Zen, Y., & Deshpande, V. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1104650 · Cited by 2,616
Masi, A. T., Hunder, G. G., Lie, J. T., Michel, B. A., Bloch, D. A., Arend, W. P., Calabrese, L. H., Edworthy, S. M., Fauci, A. S., Leavitt, R. Y., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330806 · Cited by 2,215
Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.
Churg, J., & Strauss, L. (1951) · PubMed · Cited by 1,696
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Kallenberg, C. G. M., Lamprecht, P., Hoffman, G. C., Rasmussen, N., Pusey, C. D., Özen, S., Matteson, E. L., Merkel, P. A., Flores-Suarez, L. F., Bacon, P. A., et al. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/tnnw-jw94 · Cited by 1,255
Systemic Vasculitis with Asthma and Eosinophilia: A Clinical Approach to the Churg-Strauss Syndrome
LANHAM, J. G., ELKON, K. B., PUSEY, C. D., & HUGHES, G. R. (1984) · Medicine · doi:10.1097/00005792-198403000-00001 · Cited by 1,238
Churg-Strauss Syndrome Clinical Study and Long-Term Follow-Up of 96 Patients
Guillevin, L., Cohen, P., Gayraud, M., Lhote, F., Jarrousse, B., & Casassus, P. (1999) · Medicine · doi:10.1097/00005792-199901000-00003 · Cited by 1,074
Guillevin, L., Lhote, F., Gayraud, M., Cohen, P., Jarrousse, B., Lortholary, O., Thibult, N., & Casassus, P. (1996) · Medicine · doi:10.1097/00005792-199601000-00003 · Cited by 1,000
Guillevin, L., Pagnoux, C., Seror, R., Mahr, A., Mouthon, L., & Toumelin, P. L. (2011) · Medicine · doi:10.1097/md.0b013e318205a4c6 · Cited by 951
Cited by
Pathogenesis and therapeutic interventions for ANCA-associated vasculitis
Nakazawa, D., Masuda, S., Tomaru, U., & Ishizu, A. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0145-y · Cited by 477
Emmi, G., Bettiol, A., Gelain, E., Bajema, I. M., Berti, A., Burns, S., Cid, M. C., Cohen Tervaert, J. W., Cottin, V., Durante, E., et al. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-023-00958-w · Cited by 334
Self-citationHow I treat hypereosinophilic syndromes
Klion, A. D. (2015) · Blood · doi:10.1182/blood-2014-11-551614 · Cited by 296
Caforio, A. L. P., Adler, Y., Agostini, C., Allanore, Y., Anastasakis, A., Arad, M., Böhm, M., Charron, P., Elliott, P. M., Eriksson, U., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx321 · Cited by 263
Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report
Papadopoulos, N. G., Bernstein, J. A., Demoly, P., Dykewicz, M., Fokkens, W., Hellings, P. W., Peters, A. T., Rondon, C., Togias, A., & Cox, L. S. (2015) · Allergy · doi:10.1111/all.12573 · Cited by 182
Metadata
- Authors
- Vaglio, A., Buzio, C., & Zwerina, J.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2013-01-18
- Volume
- 68
- Issue
- 3
- Pages
- 261-273
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W1988239900
- Cited by
- 284
- References
- 89
- FWCI
- 17.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art. https://app.cochat.ai/papers/10.1111/all.12088
- The paper
- Vaglio, A., Buzio, C., & Zwerina, J. (2013). Eosinophilic granulomatosis with polyangiitis (Churg–Strauss): state of the art. Allergy. https://doi.org/10.1111/all.12088
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.